The document discusses patient engagement with pharmaceutical companies on social media and online platforms. It notes a spectrum of views from mixed to positive, and advises companies to engage patients slowly and realistically, know who they are engaging with, and focus on building trust, integrity, and support through sharing and facilitating health-focused exchanges. The overarching message is for pharmaceutical companies to engage patients online in an authentic way that fosters healthy collaborations.